Literature DB >> 16952025

AHPBA/SSO/SSAT Consensus Conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006.

Jean-Nicolas Vauthey1, Michael A Choti, W Scott Helton.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16952025     DOI： 10.1245/s10434-006-9017-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  13 in total

1.  Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection.

Authors:  Nsehniitooh A Mbah; Russell E Brown; Matthew R Bower; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2012-02       Impact factor: 3.647

2.  AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.

Authors:  Elijah Dixon; Eddie Abdalla; Roderich E Schwarz; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

3.  SSAT/AHPBA Joint Symposium: Today's approaches to colorectal cancer (CRC) liver metastases.

Authors:  W Scott Helton
Journal:  J Gastrointest Surg       Date:  2011-02-01       Impact factor: 3.452

4.  AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases.

Authors:  Roderich E Schwarz; Eddie K Abdalla; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

5.  Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement.

Authors:  Robert C G Martin; Riad Salem; Rene Adam; Elijah Dixon
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

Review 6.  Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.

Authors:  Mathias Worni; Kevin N Shah; Bryan M Clary
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

7.  Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.

Authors:  Robert C G Martin; Charles R Scoggins; Dana Tomalty; Marshall Schreeder; Tiffany Metzger; Clifton Tatum; Vivek Sharma
Journal:  J Gastrointest Surg       Date:  2012-04-24       Impact factor: 3.452

8.  Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.

Authors:  Alastair L Young; Dan Wilson; Janice Ward; John Biglands; J Ashley Guthrie; K Rajendra Prasad; Giles J Toogood; Philip J Robinson; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2012-01-16       Impact factor: 3.647

9.  Population-based review of the outcomes following hepatic resection in a Canadian health region.

Authors:  Elijah Dixon; Oliver F Bathe; Andrew McKay; Isabelle You; Scot Dowden; David Sadler; Kelly W Burak; J Gregory McKinnon; Walter Miller; Francis R Sutherland
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 10.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.